the Center “Vector” has received permission to conduct clinical trials of a vaccine against coronavirus, was reported in the press service of Rospotrebnadzor.
“the First volunteers will be vaccinated on 27 July as part of the Protocol for the clinical trials,” – said in the message.
As previously reported, “RG”, “Vector” was developed and conducted preclinical trials of three vaccines against coronavirus, one of which is for internatilnal introduction.
Drug from COVID-19 Russia is working on 17 research organizations that have already indicated the existence of more than 26 types of vaccines.
